Novel cardiovascular metabolic risk factor mechanisms and therapeutic opportunities - PubMed
5 days ago
- #Therapeutic opportunities
- #Metabolic disorders
- #Cardiovascular disease
- Metabolic disorders like obesity, type 2 diabetes, and dyslipidaemia significantly increase cardiovascular risk.
- Recent clinical research shows metabolic drugs have unexpected beneficial effects on cardiovascular outcomes.
- The mechanisms of these drugs are not fully understood, highlighting the need for more research.
- This article reviews molecular and cellular pathways linking metabolic abnormalities with cardiovascular disease.
- Aims to inspire innovation in managing cardiovascular disease in metabolic dysfunction contexts.
- Suggests new research directions for better therapeutic development.